Understanding the Perspective of Youths on Undergoing Metabolic Monitoring While on Second-Generation Antipsychotics: Challenges, Insight, and Implications

被引:0
|
作者
Aouira, Nisreen [1 ,7 ]
Khan, Sohil [1 ,2 ,3 ,4 ]
Heussler, Helen [2 ,5 ]
Haywood, Alison [1 ,2 ]
Karaksha, Abdullah [1 ]
Bor, William [2 ,5 ,6 ]
机构
[1] Griffith Univ, Menzies Hlth Inst Queensland, Sch Pharm & Med Sci, Gold Coast, Australia
[2] Univ Queensland, Mater Res Inst, Brisbane, Australia
[3] Prasanna Inst Publ Hlth, Manipal, India
[4] Manipal Acad Higher Educ, Manipal Coll Pharmaceut Sci, Manipal, India
[5] Childrens Hlth Queensland Hosp & Hlth Serv, Brisbane, Australia
[6] Queensland Hlth, Ctr Childrens Hlth Res, Child & Youth Mental Hlth Serv, Brisbane, Australia
[7] Griffith Univ, Menzies Hlth Inst Queensland, Sch Pharm & Med Sci, Gold Coast 4222, Australia
关键词
youths; perspective; antipsychotics; barriers; suggestions; health; PSYCHOTROPIC MEDICATION; PHYSICAL-ACTIVITY; EXPERIENCE; BARRIERS; DEPRESSION; ADOLESCENTS; CHILDREN; CARE; PARTICIPATION; PERCEPTIONS;
D O I
10.1089/cap.2023.0016
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction: Prescription of second-generation antipsychotics (SGAs) in youths is rapidly increasing globally, despite the potential for significant adverse effects and long-term health consequences. A known adverse reaction resulting from SGAs is metabolic syndrome (MS). Youths exposed to antipsychotics are at higher risk than adults for adverse drug reactions, including adverse events such as MS (with weight gain as the most significant adverse outcome) and other long-term endocrinological abnormalities. This study aimed to explore the experiences of young patients on factors impacting barriers to metabolic monitoring of SGAs and the strategies to address those barriers thereby providing further guidance on policy and service delivery.Methods: Semi-structured interviews were conducted with patients (youths who were prescribed SGAs) who attended Child and Youth Mental Health Services. The interviews focused on barriers to monitoring and strategies to enhance rates of monitoring that could be customized across study sites.Results: Young patients revealed that none of them had any concerns or objections to receiving anthropometric metabolic measurements. However, they seemed concerned to undergo blood tests as part of the metabolic monitoring process. Specifically, youths cited their fear of the needles as barrier to undergo the required blood tests. Youths have also reported that their dislike to healthy foods and exercise being the most common challenge they face while trying to engage in a healthy lifestyle to manage the SGAs resulted weight gain.Conclusion: Prescribers are recommended to actively engage young patients about the expected SGAs-induced adverse effects, the importance of conducting metabolic monitoring, and how to prevent and minimize the expected adverse effects from the start of initiating SGAs. This could be a vital step toward a successful treatment as the insight of youths into the details of the chosen treatment can play a significant role into treatment adherence and recovery.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 50 条
  • [1] Metabolic Monitoring for Youths Initiating Use of Second-Generation Antipsychotics, 2003-2011
    Connolly, John G.
    Toomey, Timothy J.
    Schneeweiss, Maria C.
    PSYCHIATRIC SERVICES, 2015, 66 (06) : 604 - 609
  • [2] Metabolic Monitoring of Patients Prescribed Second-Generation Antipsychotics
    Dhamane, Amol D.
    Martin, Bradley C.
    Brixner, Diana I.
    Hudson, Teresa J.
    Said, Qayyim
    JOURNAL OF PSYCHIATRIC PRACTICE, 2013, 19 (05) : 360 - 374
  • [3] Metabolic monitoring of psychiatric patients on second-generation antipsychotics
    Maria Markopoulou
    Olga Georgiadou
    Keranio Tsiftsoglou
    Konstantinos Bobotas
    Annals of General Psychiatry, 7 (Suppl 1)
  • [4] Practitioners' Perspective on Metabolic Monitoring of Second-Generation Antipsychotics: Existing Gaps in Knowledge, Barriers to Monitoring, and Strategies
    Aouira, Nisreen
    Khan, Sohil
    Heussler, Helen
    Haywood, Alison
    Karaksha, Abdullah
    Bor, William
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2022, 32 (05) : 296 - 303
  • [5] Second-generation antipsychotics and the metabolic syndrome
    Prakash S. Masand
    Rajnish Mago
    Current Psychiatry Reports, 2005, 7 (3) : 153 - 154
  • [7] Second-generation antipsychotics and metabolic syndrome
    Farines, Magali
    Alberto-Gondouin, Marie-Christine M. C.
    PHARMACY WORLD & SCIENCE, 2008, 30 (05): : 720 - 720
  • [8] Enhancing metabolic monitoring for children and adolescents using second-generation antipsychotics
    Coughlin, Mary
    Goldie, Catherine L.
    Tregunno, Deborah
    Tranmer, Joan
    Kanellos-Sutton, Marina
    Khalid-Khan, Sarosh
    INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2018, 27 (03) : 1188 - 1198
  • [9] Metabolic risk in selected second-generation antipsychotics
    Kerna, V.
    Nosalova, G.
    Ondrejka, I
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2010, 111 (12): : 640 - 643
  • [10] Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management
    Krill, Rebecca A.
    Kumra, Sanjiv
    ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2014, 5 : 171 - 182